Paroxetine (paxil) overdose: A pediatric focus

Veterinary and Human Toxicology

Volumn 39, Issue 2, 1997, Pages 86-88

  Myers, Lanita B ^a   Krenzelok, Edward P ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

ARTICLE; CHILD; CLINICAL ARTICLE; DROWSINESS; DRUG EFFECT; DRUG OVERDOSE; FEMALE; HUMAN; MALE; MYDRIASIS; ORAL DRUG ADMINISTRATION; PEDIATRICS; SEDATION; STOMACH LAVAGE; SYMPTOMATOLOGY; TACHYCARDIA; TREMOR; VERTIGO;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; OVERDOSE; PAROXETINE; POISON CONTROL CENTERS; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 0030903148     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Product Information: Paxi1 (R): Paroxetine hydrochloride. Smith Kline Beecham Pharmaceutical s, Philadelphia, PA, 1993.
2. Gorman SE, Rice T, Simmons HF: Paroxetine overdose. Am J Emerg Med 11 : 682, 1993.
3. Sherman TL, McDougle CJ, Price LH: Paroxetine: A new serotonin reuptake inhibitor for the treatment of depression. Conn Med 57: 587-592, 1993.
4. Tulloch IF, Johnson AM: The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. Jour Clin Psychiatr 53: 7-12, 1992.
5. Litovitz TL, Clark LR, Soloway RA: 1993 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 12: 546-584, 1994.
6. Feighner JP, Boyer WF: Paroxetine in the treatment of deoression: A comparison with imipramine and placebo. J Clin Psychiatr 53: 44-47, 1992.
7. Dechant KL, Clissold SP: Paroxetine: A review of its pharmaco-dynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drug 41 : 225-253, 1991.
8. DeVane CL: Pharmacokinetics of the selective serotonin reuptake inhibitors. J Clin Psychiatr 53: 13-20, 1992.
9. AHFS Drug Information: Paroxetine hydrochloride. 1405-1406, 1994.
10. Kaye CM, Haddock RE, Langley PE et al : A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand 80 (suppl 350): 60-75, 1989.
11. Nemeroff CB: Paroxetine: An overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatnent of depression. J Clin Psychophar 13: 6 (suppl 2): 10S-16S, 1993.
12. Grimsley SR, Jann MW: Paroxetine, sertraline, and fluvoxamine: New selective sertonin reuptake inhibitors. Clin Pharm 11: 930-957, 1992.
13. Boyer WF, Feighner JP: An overview of paroxetine. J Clin Psychiatr 53: 3-6, 1992.
14. Boyer WF, Blumhardt CL: The safety profile of paroxetine. J Clin Psychiatr 53: 61-66, 1992.
15. DeVane CL: Pharmacokinetics of the newer antidepressants: Clinical relevance. Am J Med 97 (suppl 6A): 13S-21S, 1994.